Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Business Summary
Logo Celgene Corporation
Develops human pharmaceuticals and agrochemicals

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases.

Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax.

Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Number of employees : 7 467 people.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Biopharmaceuticals - Net Product Sales - REVLIMID6,97463.8%8,18763.9% +17.4%
Biopharmaceuticals - Net Product Sales - POMALYST/IMNOVID1,31112%1,61412.6% +23.14%
Biopharmaceuticals - Net Product Sales - OTEZLA1,0179.3%1,27910% +25.74%
Biopharmaceuticals - Net Product Sales - ABRAXANE973.408.9%992.007.7% +1.91%
Biopharmaceuticals - Net Product Sales - VIDAZA608.005.6%628.004.9% +3.29%
Biopharmaceuticals - Net Product Sales - THALOMID152.101.4%132.001% -13.21%
Biopharmaceuticals - Net Product Sales - ISTODAX79.300.7%76.000.6% -4.16%
Biopharmaceuticals - Net Product Sales - Azacitidine for Inj66.000.6%36.000.3% -45.45%
Biopharmaceuticals - Net Product Sales - Other Revenue44.600.4%---
Biopharmaceuticals - Net Product Sales - Other4.300%---
Other--39.000.3%-
Biopharmaceuticals - Net Product Sales - IDHIFA--20.000.2%-
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States7,01064.2%8,32464.9% +18.75%
Europe3,04627.9%3,32725.9% +9.21%
All Other1,17310.7%1,35210.5% +15.23%
Managers
NameAgeSinceTitle
Mark Alles592004Chairman, President, CEO & COO
David V. Elkins, MBA502018Chief Financial Officer & Executive Vice President
Joseph S. Camardo, MD63-Senior Vice President-Global Medical Affairs
Jay T. Backstrom, MD-2008Chief Medical Officer
Rupert J. Vessey, PhD532015President-Research & Early Development
Michael D. Casey722002Lead Independent Director
James J. Loughlin, CPA752007Independent Director
Ernest Mario, PhD792007Independent Director
Carrie Smith Cox612009Independent Director
Michael A. Friedman, MD742011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 978,263,010 700,681,686 71.6% 274,900,000 28.1% 71.6%
Shareholders
NameEquities%
The Vanguard Group, Inc. 50,937,201 7.24%
BlackRock Fund Advisors 39,336,027 5.59%
SSgA Funds Management, Inc. 28,588,600 4.06%
Edgewood Management LLC 13,924,544 1.98%
Orbis Investment Management Ltd. 10,255,794 1.46%
Northern Trust Investments, Inc. 9,198,192 1.31%
Geode Capital Management LLC 9,189,754 1.31%
Henderson Global Investors Ltd. 9,070,041 1.29%
Fidelity Management & Research Co. 7,973,653 1.13%
Norges Bank Investment Management 6,904,337 0.98%
Holdings
NameEquities%Valuation
Agios Pharmaceuticals Inc (AGIO) 6,718,43311.6%542,311,912 USD
Beigene Ltd (6160) 32,746,4164.26%443,494,536 USD
Acceleron Pharma Inc (XLRN) 6,118,47913.3%330,520,236 USD
Crispr Therapeutics AG (CRSP) 2,800,7725.89%158,719,749 USD
Atara Biotherapeutics Inc (ATRA) 1,154,5402.55%47,278,413 USD
Epizyme Inc (EPZM) 3,674,6405.29%43,360,752 USD
Jounce Therapeutics Inc (JNCE) 3,456,46310.6%27,133,235 USD
Zymeworks Inc (ZYME) 1,539,4834.82%21,629,736 USD
Oncomed Pharmaceuticals Inc (OMED) 2,970,5887.72%6,832,352 USD
Alliqua Biomedical Inc (ALQA) 804,61016.1%2,091,986 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  CELG:US
- Reuters Code :  CELG.O
- Datastream Code :  
Company contact information
Celgene Corporation
86 Avenue Morris
NJ 07901 Summit, New Jersey
États-Unis (les)

Phone : +1 908 673 9000
Fax : +1
Internet : http://www.celgene.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
CELGENE CORPORATION-15.39%61 460
JOHNSON & JOHNSON0.59%376 820
PFIZER20.13%253 595
NOVARTIS-0.80%216 184
ROCHE HOLDING LTD.-4.06%211 637
MERCK AND COMPANY24.36%186 114
AMGEN16.35%131 526
ABBOTT LABORATORIES19.87%120 171
ELI LILLY AND COMPANY26.55%113 563
SANOFI4.55%109 834
BRISTOL-MYERS SQUIBB COMPANY0.33%99 218
GLAXOSMITHKLINE13.18%97 628
ASTRAZENECA9.37%93 281
NOVO NORDISK A/S-10.27%89 874
BAYER-27.67%80 647
ALLERGAN PLC13.75%63 826
SHIRE16.22%54 502
ASTELLAS PHARMA INC38.69%35 399
CHUGAI PHARMACEUTICAL CO LTD21.84%34 812
TAKEDA PHARMACEUTICAL CO LTD-27.49%33 184
JIANGSU HENGRUI MEDICINE CO LTD11.47%31 799
Connections : Celgene Corporation
California Institute for Regenerative Medicine
Orbus Therapeutics, Inc.
Biotechnology Innovation Organization
Elstar Therapeutics, Inc.
Sidecar Therapeutics, Inc.
PharmAkea, Inc.
Tulane University (Louisiana)
University of Pennsylvania Museum of Archaeology & Anthropolog
American College of Physicians Foundation
Mali Health Organizing Project
Rosemont College
Humacyte, Inc.
Gilda's Club New York City, Inc.
Pharmaceutical Research & Manufacturers of America
Rutgers University Foundation
European Federation of Pharmaceutical Industries & Assns
Gladstone Foundation (CA)
HealthCare Institute of New Jersey
Taxis Pharmaceuticals, Inc.
Smith & Nephew A/S (Denmark)
Delpor, Inc.
City of Hope National Medical Center
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem